Relay Therapeutics, Inc. announced that it has entered into a securities purchase agreement to issue 2,500,000 shares at a price of $12 per share for the gross proceeds of $30 million on January 8, 2024. The transaction will include participation from new investor, Nextech. The transaction is expected to close on January 10, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.37 USD | +3.49% | +6.88% | -42.14% |
Mar. 12 | Transcript : Relay Therapeutics, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 07:30 AM | |
Feb. 23 | Relay Therapeutics Q4 Loss Widens, Reports No Revenue | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.14% | 843M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- RLAY Stock
- News Relay Therapeutics, Inc.
- Relay Therapeutics, Inc. announced that it expects to receive $30 million in funding